Testing effectiveness (Phase 2)Looking for participantsNCT06492850
What this trial is testing
Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa
Who this might be right for
X-Linked Retinitis Pigmentosa (XLRP)
Frontera Therapeutics 32